Impact of antitumour necrosis factor therapy on surgery in inflammatory bowel disease: a population-based study
Objective It is unclear whether widespread use of biologics is reducing inflammatory bowel disease (IBD) surgical resection rates. We designed a population-based study evaluating the impact of early antitumour necrosis factor (TNF) on surgical resection rates up to 5 years from diagnosis.Design We e...
Saved in:
| Main Authors: | Richard C G Pollok, Rebecca Cannings-John, Philip Harborne, A Barney Hawthorne, Bradley Arms-Williams, Alexander Berry, Anjali Trivedi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-07-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/11/1/e001373.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Learning the Lessons of Antitumour Necrosis Factor Therapy-Associated Psoriasis
by: Matt Shale, et al.
Published: (2009-01-01) -
Design and synthesis of phenylthiophosphoryl dichloride derivatives and evaluation of their antitumour and anti-inflammatory activities
by: Chunyun Xu, et al.
Published: (2025-01-01) -
Antitumour necrosis factor-α agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort
by: Susan Hutfless, et al.
Published: (2020-12-01) -
Antitumour Activity of Dehydroxymethylepoxyquinomycin (DHMEQ): a Literature Review
by: K. Umezawa, et al.
Published: (2021-04-01) -
Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses
by: Katrin Kramer, et al.
Published: (2019-01-01)